See more : Morgan Stanley India Investment Fund, Inc. (IIF) Income Statement Analysis – Financial Results
Complete financial analysis of Cannabotech LTD (CNTC.TA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cannabotech LTD, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Sparebanken Møre (MORG.OL) Income Statement Analysis – Financial Results
- Hunter Technology Corp. (HOILF) Income Statement Analysis – Financial Results
- Offshore Oil Engineering Co.,Ltd (600583.SS) Income Statement Analysis – Financial Results
- Argus Capital Corp. (ARGUW) Income Statement Analysis – Financial Results
- Shiyan Taixiang Industry Co.,Ltd. (301192.SZ) Income Statement Analysis – Financial Results
Cannabotech LTD (CNTC.TA)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://cannabotech.com
About Cannabotech LTD
CannaboTech Ltd engages in developing cannabinoid-based medication and healthcare products. It provides drugs for various indications; personalized cannabinoid-based products; and CBD-based skincare and food-supplement products. The company is based in Rishon LeZion, Israel.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 1.22M | 0.00 | 153.00K | 0.00 | 0.00 |
| Cost of Revenue | 2.48M | 0.00 | 968.00K | 498.00K | 85.00K |
| Gross Profit | -1.26M | 0.00 | -815.00K | -498.00K | -85.00K |
| Gross Profit Ratio | -103.12% | 0.00% | -532.68% | 0.00% | 0.00% |
| Research & Development | 3.71M | 0.00 | 15.68M | 9.29M | 4.60M |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 9.99M | 0.00 | 12.69M | 3.40M | 1.82M |
| Other Expenses | 1.67M | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 15.37M | 0.00 | 28.38M | 12.69M | 6.42M |
| Cost & Expenses | 17.84M | 0.00 | 29.34M | 13.19M | 6.50M |
| Interest Income | 510.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 304.00K | 53.00K | 7.00K |
| Depreciation & Amortization | 1.31M | 228.49K | 788.00K | 498.00K | 85.00K |
| EBITDA | -14.81M | 0.00 | -28.40M | -12.69M | -6.42M |
| EBITDA Ratio | -1,214.93% | 0.00% | -18,564.05% | 0.00% | 0.00% |
| Operating Income | -16.63M | 0.00 | -29.19M | -13.19M | -6.50M |
| Operating Income Ratio | -1,363.82% | 0.00% | -19,079.08% | 0.00% | 0.00% |
| Total Other Income/Expenses | 510.00K | 0.00 | -304.00K | -53.00K | -7.00K |
| Income Before Tax | -16.11M | 0.00 | -29.50M | -13.24M | -6.51M |
| Income Before Tax Ratio | -1,321.99% | 0.00% | -19,277.78% | 0.00% | 0.00% |
| Income Tax Expense | 7.00K | 0.00 | 37.00K | 17.00K | 1.00K |
| Net Income | -16.12M | 0.00 | -29.53M | -13.26M | -6.51M |
| Net Income Ratio | -1,322.56% | 0.00% | -19,301.96% | 0.00% | 0.00% |
| EPS | -7.69 | 0.00 | -19.98 | -9.08 | -4.45 |
| EPS Diluted | -7.69 | 0.00 | -19.98 | -9.08 | -4.45 |
| Weighted Avg Shares Out | 2.10M | 0.00 | 1.48M | 1.46M | 1.46M |
| Weighted Avg Shares Out (Dil) | 2.10M | 0.00 | 1.48M | 1.46M | 1.46M |
Source: https://incomestatements.info
Category: Stock Reports